EWM
TMO icon

Elite Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Elite Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-620
Closed -$73K – 706
2014
Q2 		$73K Hold
620
– – 0.07% 94
2014
Q1 		$75K Hold
620
– – 0.06% 96
2013
Q4 		$69K Hold
620
– – 0.05% 134
2013
Q3 		$57K Buy
+620
New +$56.1K 0.05% 161

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Elite Wealth Management's TMO Position: Q3 2014 in Review

Elite Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q3 2014, closing a stake of 620 shares — an estimated $73K sold.

Elite Wealth Management first reported a position in TMO in Q3 2013 and held it in 4 quarters. The position peaked at $75K in Q1 2014. 917 funds tracked by Wall St. Rank hold TMO as of Q3 2014.

  • Elite Wealth Management reported no remaining Thermo Fisher Scientific position as of Q3 2014 after selling out during the quarter.
  • Elite Wealth Management sold 620 Thermo Fisher Scientific shares in Q3 2014, an estimated $73K.
  • Elite Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 4 quarters.
  • Elite Wealth Management's Thermo Fisher Scientific position peaked at $75K in Q1 2014.
  • 917 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2014.

Based on Elite Wealth Management's 13F filing for Q3 2014, filed 23 Nov 2016.